US 10160753
Indazole compounds as IRAK4 inhibitors
granted A61PA61P1/02A61P1/16
Quick answer
US patent 10160753 (Indazole compounds as IRAK4 inhibitors) held by Aurigene Discovery Technologies Limited expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61P, A61P1/02, A61P1/16, A61P1/18, A61P11/06